Navigation Links
Pneumonia Effectively Treated with Short-Term Antibiotic Course

Recent research has revealed that taking antibiotics for three days rather than the usual concept of seven to 10 days is equally effective in the treatment of common pneumonia // .

According to researchers this could also help to curb the rising problem of antibiotic-resistant bacteria,

Lead researcher Dr. Jan M Prins, an internist in infectious diseases at the Academic Medical Center, in Amsterdam said,’The question is how long you should treat common pneumonia. It turns out that three days is sufficient in children, and we now find the same in adults.’

The research team compared the effectiveness of three days of amoxicillin treatment with eight days of treatment in adults in cases of mild to moderate-severe pneumonia.

119 patients who had improved after three days of treatment with intravenous amoxicillin, and then assigned oral amoxicillin or a placebo for five days were taken as the subjects of the study.v It was found that 93 percent of the patients treated for three day or eight days, got better. Prins said, ‘For patients who responded after three days of antibiotic treatment, you could stop antibiotics and the results were comparable for those treated for eight days.’

The advantage lay in the fact that patients do not have to take in more medication than necessary. ‘In addition, there is a relation between how many antibiotics are used in a community and the rate of resistance among bacteria,’ he said. ‘If you can reduce the use of antibiotics, you can reduce the rate of resistance.’

The results of the research have been published in the June 10 issue of the British Medical Journal.

However Prins has cautioned that all diseases treated with antibiotics cannot become candidates for short-course treatment.

According to Dr. John Paul, from the Royal Sussex County Hospital, in England, and author of an accompanying editorial in the journal, ‘There is a lack of clear evidence to allow clinicians to know the optimal duration of antibiotic therapy for many common infections. He added, ‘We know that some infections do require long-term therapy to prevent relapse. We know for others that short courses of antibiotics are as good as long courses.’

‘This concept is smart,’ said Philip Tierno Jr., director of clinical microbiology and immunology at New York University Medical Center. ‘It eliminates three big problems: The cost to individuals of some of these newer antibiotics, adverse reactions and complications, and the development of resistanc.’


'"/>




Related medicine news :

1. Toxin connected to Flesh-eating Pneumonia in Kids
2. A new Vaccine for Pneumonia
3. The After Effects Of Pneumonia
4. Acid Suppressive Drugs Found To Increase The Risk for Pneumonia
5. Tsunami Survivors Face Pneumonia Threat
6. New Vaccine Found To Be Effective In Reducing Childhood Pneumonia
7. Zinc Effective In Helping Kids Recover From Pneumonia
8. Bronchiolo-alveolar Carcinoma Shows Sonographic Pattern Of Pneumonia
9. Pneumonia Claims 30 Lives In Pakistan
10. Pneumonia Vaccine Effective Among Children
11. Five Tribal Children Succumbs to Pneumonia in Orissa
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... A stressful work environment ... can also decrease overall productivity and performance in the workplace. The goal of Clearview ... the last few weeks of April, Clearview Resolution Services will be shutting down the ...
(Date:4/25/2017)... ... April 25, 2017 , ... A ... student test score performance for the 2015-16 school year across Wisconsin’s public schools, ... Though it highlights important patterns in student test score performance, the report’s limited ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is ... using Invisalign® in Lutz, FL. With the help of this highly-effective, yet ... with fewer potential complications, more discretion and less pain. , Drs. Sarah Jockin, ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... April 24, 2017 Solentim, the developer ... the addition of a major new product line ... Seeding,). The VIPS has been developed for automatically ... microplates as part of the process to generate ... simple and more reliable solution when compared to ...
(Date:4/20/2017)... 20, 2017  Vivify Health, the pioneer and market ... awarded a very significant patent for the advancement of ... care via digital health.  This landmark patent provides the ... further secures Vivify,s position as the leader in remote ... the first company to apply consumer mobile devices, wireless ...
(Date:4/20/2017)... MARLBOROUGH, Mass. , April 20, 2017 /PRNewswire/ ... company developing innovative therapeutics that address significant unmet ... new data from the Company,s consumer product development ... technology, at the Society for Investigative Dermatology (SID) ... is to advance and promote the sciences relevant ...
Breaking Medicine Technology: